期刊
ONCOGENE
卷 27, 期 45, 页码 5886-5893出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2008.269
关键词
tumour; cancer; regulatory T cells; development of regulatory T cells; Th17; Il-23
资金
- Association for International Cancer Research
- NIHR Biomedical Research Centre
- MRC [G117/488] Funding Source: UKRI
- Medical Research Council [G117/488] Funding Source: researchfish
Clinicians and scientists have long questioned whether the immune system has a role in destroying cancerous tissue. Studies performed in animal models have, however, recently revealed that the immune system can, at least in principle, effectively control tumours. In parallel with these findings, a large body of evidence indicates that although the immune system has the capacity to control tumours, there are also regulatory mechanisms that subdue these responses. A major challenge of tumour immunotherapy, therefore, is to find ways of disabling these regulatory functions while restoring or priming any immune responses that are protective.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据